Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
BNT-111 by BioNTech for Melanoma: Likelihood of Approval
BNT-111 is under clinical development by BioNTech and currently in Phase II for Melanoma. According to GlobalData, Phase II drugs...
Data Insights
BNT-111 by BioNTech for Metastatic Melanoma: Likelihood of Approval
BNT-111 is under clinical development by BioNTech and currently in Phase II for Metastatic Melanoma. According to GlobalData, Phase II...